Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PVR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
KBTBD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACTB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR3620 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMB7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAJC7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMSB4X - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
C17orf80 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RHBDD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ILF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRMU - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPS18B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CKAP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCGF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTPAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMARCE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAD17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABCB7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDK8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on